CBX3 and neoplasm: The study by Sun et al. [20] found Cbx3/HP1γ insufficiency mice were treated with Cbx3/HP1γ‐insufficient CD8+ T cells, which caused changes of tumor immune environment, alleviated the tumor burden and, in turn, suppressed the tumor growth.